Back to News
Market Impact: 0.35

Zscaler stock price target raised to $250 by Truist on growth outlook

Source: Investing.com

Analyst InsightsCybersecurity & Data PrivacyCorporate Guidance & OutlookCompany FundamentalsArtificial Intelligence
Zscaler stock price target raised to $250 by Truist on growth outlook

Truist raised its Zscaler price target to $250 from $200 and maintained a Buy rating; at the cited share price of $212.73, the target implies about 17% upside. Zscaler targets more than $8 billion in annual recurring revenue by fiscal 2031, or roughly 17% annual growth, with a faster AI-adoption scenario pointing to about $10 billion and roughly 22% growth. The article also cites 25% revenue growth, a 77% gross margin and multiple other firms raising their price targets.

Analysis

The stated $250 target implies less than 20% upside from the quoted share price—not the headline’s “nearly 200%.” More importantly, multiple target increases after Investor Day are not independent proof of accelerated demand: they largely capitalize a long-dated management framework. The market mechanism to watch is whether products outside core user security increase platform attach and customer spend without raising acquisition costs or weakening retention. If so, Zscaler can defend its position against platform competitors such as Palo Alto Networks and CrowdStrike; if AI features are bundled without incremental willingness to pay, the narrative may lift expectations faster than revenue. The standalone AI-security run rate is too early to establish material earnings contribution; the potential value is broader product pull-through, which needs verification in reported bookings, retention, and customer adoption.

Near term (days to weeks), positive analyst revisions may support sentiment, but clustered target increases also raise the risk that good news is already reflected. Over 1–3 months, quarterly billings/RPO, net retention, and management commentary on non-user product attach are better catalysts than target changes. Over 6–18 months, delivery against ARR growth and operating leverage matters more than the FY2031 endpoint. The key missing input is valuation versus growth-adjusted peers; without it, the targets do not establish attractive risk/reward. Falsify the constructive thesis if growth or retention decelerates, margin goals require excessive sales investment, or guidance weakens.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.45

Ticker Sentiment

ZS0.75

Key Decisions for Investors

  • Do not chase solely on the analyst-target cluster. Treat Zscaler as a watchlist long until valuation and the next reported demand indicators are assessed.
  • Consider initiating or adding on a market-driven pullback only if billings/RPO and net retention remain consistent with the growth framework; size for execution and multiple-compression risk.
  • Track quarterly evidence that Branch/Cloud, Data Security, and AI features are increasing customer attach and spend. If adoption is mostly bundled with no improvement in customer economics, reduce the growth premium thesis.
  • Avoid treating the FY2031 ARR ambition or the AI-accelerated scenario as a near-term earnings catalyst; reassess on guidance revisions, retention, and operating-margin progress.

More News

From AllMind Research

Browse all research